A study comparing efficacy of Ranibizumab and Aflibercept in patients with neovascular age related macular degeneration.
Phase of Trial: Phase IV
Latest Information Update: 22 May 2017
At a glance
- Drugs Aflibercept (Primary) ; Ranibizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 22 May 2017 New trial record